Cargando…
Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review
A major advance in drug discovery and targeted therapy directed at cancer cells may be achieved by the exploitation and immunomodulation of their unique biological properties. This review summarizes our efforts to develop novel chemo-thermo-immunotherapy (CTI therapy) by conjugating a melanogenesis...
Autores principales: | Tamura, Yasuaki, Ito, Akira, Wakamatsu, Kazumasa, Kamiya, Takafumi, Torigoe, Toshihiko, Honda, Hiroyuki, Yamashita, Toshiharu, Uhara, Hisashi, Ito, Shosuke, Jimbow, Kowichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223671/ https://www.ncbi.nlm.nih.gov/pubmed/35742905 http://dx.doi.org/10.3390/ijms23126457 |
Ejemplares similares
-
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles
por: Jimbow, Kowichi, et al.
Publicado: (2013) -
Growth Inhibition of Re-Challenge B16 Melanoma Transplant by Conjugates of Melanogenesis Substrate and Magnetite Nanoparticles as the Basis for Developing Melanoma-Targeted Chemo-Thermo-Immunotherapy
por: Takada, Tomoaki, et al.
Publicado: (2009) -
Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development
por: Wakamatsu, Kazumasa, et al.
Publicado: (2022) -
A Sulfur Containing Melanogenesis Substrate, N-Pr-4-S-CAP as a Potential Source for Selective Chemoimmunotherapy of Malignant Melanoma
por: Tamura, Yasuaki, et al.
Publicado: (2023) -
Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma
por: Hida, Tokimasa, et al.
Publicado: (2020)